BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9237794)

  • 1. T-cell lymphocytic lymphoma involving the prostate presenting as elevated PSA in paraplegia: case report.
    Johnson TR; Barber DB; Teichman JM; Able AC
    J Spinal Cord Med; 1996 Oct; 19(4):258-60. PubMed ID: 9237794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary manifestation of small Lymphocytic Lymphoma in the Prostate: A case report.
    Kassar O; Gouiaa N; Mdhaffar M; Bellaaj H; Mseddi S; Boudawara T; Mhiri N; Elloumi M
    Tunis Med; 2015 Apr; 93(4):249-58. PubMed ID: 26375744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostatic adenocarcinoma diagnosed by prostate-specific antigen analysis of pleural fluid.
    Brown GA; Ginsberg PC; Harkaway RC
    Urol Int; 1998; 60(3):197-8. PubMed ID: 9644796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenocarcinoma of the prostate in a 41-year-old man with XXY karyotype and chronic lymphocytic leukemia: report of a case.
    Pienkos EJ; Meisner LF
    J Urol; 1991 Jan; 145(1):148-50. PubMed ID: 1984078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemistry of lymphocyte B-cell lymphoma of the prostate gland.
    Williams E; Hanchard B; Brooks SE; Douglas LL
    West Indian Med J; 1992 Sep; 41(3):126-9. PubMed ID: 1441455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
    Sheridan T; Herawi M; Epstein JI; Illei PB
    Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate adenocarcinoma manifesting as generalized lymphadenopathy.
    Moura FM; Garcia LT; Castro LP; Ferrari TC
    Urol Oncol; 2006; 24(3):216-9. PubMed ID: 16678051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of prostate cancer in 34 year old man presenting with generalized lymphadenopathy mimicking malignant lymphoma.
    Ahn MJ; Oh SJ; Lee YY; Jung TJ; Kim IS; Choi IY; Jang SJ; Park YW; Shin KY; Kim YS
    J Korean Med Sci; 1997 Jun; 12(3):262-5. PubMed ID: 9250926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An unusual pathological finding of chronic lymphocitic leukemia and adenocarcinoma of the prostate after transurethral resection for complete urinary retention: case report.
    Ballario R; Beltrami P; Cavalleri S; Ruggera L; Zorzi MG; Artibani W
    BMC Cancer; 2004 Dec; 4():95. PubMed ID: 15615590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis of leukemic infiltration of the prostate p6ompted by PSA elevation].
    Pérez Arbej JA; López Carreira M; Arnaiz Esteban F; Martínez Pérez E; Nogueras Gimeno MA; Espuela Orgaz R; Crespo Mayor V
    Actas Urol Esp; 1996; 20(10):892-4. PubMed ID: 9139533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated prostate-specific antigen: a case report and analysis.
    Hicks RJ
    J Fam Pract; 1993 Sep; 37(3):284-8. PubMed ID: 7691981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prostatic endometrioid carcinoma: a case report].
    Arai G; Kawakami S; Kamata S; Ajima J; Takagi K
    Hinyokika Kiyo; 1997 Oct; 43(10):755-7. PubMed ID: 9395916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mucinous adenocarcinoma of the prostate: a case report and review of 32 cases on immunohistochemical study of both PSA and CEA].
    Furuta A; Naruoka T; Hasegawa N; Suzuki Y; Ikemoto I; Oishi Y
    Nihon Hinyokika Gakkai Zasshi; 2003 Jul; 94(5):570-3. PubMed ID: 12910933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary mucin-producing urothelial-type adenocarcinoma of prostate: report of 15 cases.
    Osunkoya AO; Epstein JI
    Am J Surg Pathol; 2007 Sep; 31(9):1323-9. PubMed ID: 17721186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate-specific antigen (PSA) immunohistochemistry in the presence of a normal serum PSA as an aid to diagnosis of adenocarcinoma of unknown primary site.
    Harper CL; Lofts FJ; Otter M; Mansi JL
    Br J Hosp Med; 1996 Mar 20-Apr 2; 55(6):367-8. PubMed ID: 8696637
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prostatic chronic lymphocytic leukemia. Report of 2 cases].
    Nouri M; Ibnattya A; Elkhader K; Moudouni S; Hachimi M; Lakrissa A
    Ann Urol (Paris); 1999; 33(4):268-70. PubMed ID: 10510709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Best practices recommendations in the application of immunohistochemistry in the prostate: report from the International Society of Urologic Pathology consensus conference.
    Epstein JI; Egevad L; Humphrey PA; Montironi R;
    Am J Surg Pathol; 2014 Aug; 38(8):e6-e19. PubMed ID: 25029122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Saturation biopsies for prostate cancer detection: effectiveness, safety and predictive factors.
    Utrera NM; Sánchez AT; Rodríguez-Antolín A; Martín-Parada A; Lora D; Passas J; González RD
    Arch Esp Urol; 2011 Jun; 64(5):421-6. PubMed ID: 21705814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of prostatic cancer with a low PSA level accompanied with cystic formation requiring differentiation from adenocarcinoma of the seminal vesicle].
    Itami Y; Nagai Y; Kobayashi Y; Shimizu N; Yamamoto Y; Minami T; Hayashi T; Nozawa M; Yoshimura K; Ishii T; Uemura H
    Hinyokika Kiyo; 2012 Jul; 58(7):349-53. PubMed ID: 22895132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of free/total prostate specific antigen in the early diagnosis of prostate cancer (study of 105 patients)].
    de la Taille A; Houlgatte A; Houdelette P; Berlizot P; Ramirez J; Ricordel I
    Prog Urol; 1997 Apr; 7(2):240-5. PubMed ID: 9264766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.